- Home
- FBK vs OCUL Comparison
FBK vs OCUL Comparison
Compare FBK & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBK
- OCUL
- Stock Information
- Founded
- FBK 1906
- OCUL 2006
- Country
- FBK United States
- OCUL United States
- Employees
- FBK N/A
- OCUL 274
- Industry
- FBK Major Banks
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- FBK Finance
- OCUL Health Care
- Exchange
- FBK Nasdaq
- OCUL Nasdaq
- Market Cap
- FBK 2.1B
- OCUL 1.8B
- IPO Year
- FBK 2016
- OCUL 2014
- Fundamental
- Price
- FBK $48.37
- OCUL $11.71
- Analyst Decision
- FBK Buy
- OCUL Strong Buy
- Analyst Count
- FBK 4
- OCUL 7
- Target Price
- FBK $58.50
- OCUL $17.33
- AVG Volume (30 Days)
- FBK 543.0K
- OCUL 2.6M
- Earning Date
- FBK 07-14-2025
- OCUL 08-06-2025
- Dividend Yield
- FBK 1.55%
- OCUL N/A
- EPS Growth
- FBK N/A
- OCUL N/A
- EPS
- FBK 1.94
- OCUL N/A
- Revenue
- FBK $410,807,000.00
- OCUL $59,647,000.00
- Revenue This Year
- FBK $35.47
- OCUL N/A
- Revenue Next Year
- FBK $20.14
- OCUL $20.85
- P/E Ratio
- FBK $25.25
- OCUL N/A
- Revenue Growth
- FBK N/A
- OCUL N/A
- 52 Week Low
- FBK $38.83
- OCUL $5.79
- 52 Week High
- FBK $58.88
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- FBK 62.63
- OCUL 76.76
- Support Level
- FBK $48.04
- OCUL $11.23
- Resistance Level
- FBK $49.22
- OCUL $11.47
- Average True Range (ATR)
- FBK 1.26
- OCUL 0.44
- MACD
- FBK 0.08
- OCUL 0.07
- Stochastic Oscillator
- FBK 77.11
- OCUL 92.54
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.